BlackRock Advisors’s GALENA BIOPHARMA INC COM RXII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-106,061
| Closed | -$37K | – | 3724 |
|
|
2016
Q3 | $37K | Buy |
106,061
+21,790
| +26% | +$7.6K | ﹤0.01% | 3260 |
|
|
2016
Q2 | $39K | Sell |
84,271
-2,620
| -3% | -$1.21K | ﹤0.01% | 3234 |
|
|
2016
Q1 | $118K | Buy |
86,891
+11,922
| +16% | +$16.2K | ﹤0.01% | 2795 |
|
|
2015
Q4 | $110K | Sell |
74,969
-29,416
| -28% | -$43.2K | ﹤0.01% | 2837 |
|
|
2015
Q3 | $165K | Sell |
104,385
-3,256
| -3% | -$5.15K | ﹤0.01% | 2793 |
|
|
2015
Q2 | $183K | Buy |
107,641
+12,363
| +13% | +$21K | ﹤0.01% | 2802 |
|
|
2015
Q1 | $132K | Buy |
95,278
+25,592
| +37% | +$35.5K | ﹤0.01% | 2882 |
|
|
2014
Q4 | $105K | Sell |
69,686
-3,291
| -5% | -$4.96K | ﹤0.01% | 2985 |
|
|
2014
Q3 | $150K | Sell |
72,977
-1,311
| -2% | -$2.7K | ﹤0.01% | 2747 |
|
|
2014
Q2 | $227K | Sell |
74,288
-10,021
| -12% | -$30.6K | ﹤0.01% | 2525 |
|
|
2014
Q1 | $211K | Buy |
84,309
+5,729
| +7% | +$14.3K | ﹤0.01% | 2586 |
|
|
2013
Q4 | $390K | Buy |
78,580
+13,700
| +21% | +$68K | ﹤0.01% | 2203 |
|
|
2013
Q3 | $148K | Buy |
64,880
+11,454
| +21% | +$26.1K | ﹤0.01% | 2706 |
|
|
2013
Q2 | $119K | Buy |
+53,426
| New | +$119K | ﹤0.01% | 2774 |
|